Stay updated on Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page's revision history shows an addition of Revision: v3.3.4 and a deletion of Revision: v3.3.3. This reflects metadata updates rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-01-14T01:46:47.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    A new Locations section including North Holland was added, and the HHS Vulnerability Disclosure and North Holland Locations entries were removed; the page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T08:38:51.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.1 to v3.3.2. No changes to the study details or substantive content.
    Difference
    0.1%
    Check dated 2025-12-01T16:42:09.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Added a note that publications are automatically filled from PubMed and may not all be about the study, and updated the revision to v3.3.1. The previous wording stating publications come from PubMed (and the older revision v3.2.0) was removed.
    Difference
    0.1%
    Check dated 2025-11-24T12:20:30.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The notice about a lapse in government funding and possible update delays has been removed; the study page content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:22:15.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Comparison shows no substantive changes to the study details (eligibility, endpoints, or locations). The observed differences are minor visual/layout tweaks and do not affect the information presented.
    Difference
    0.4%
    Check dated 2025-11-03T00:58:18.000Z thumbnail image

Stay in the know with updates to Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page.